![](/img/cover-not-exists.png)
PCV52 LOSARTAN-BASED VERSUS ATENOLOL-BASED THERAPY IN PATIENTS WITH HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY: AN ECONOMIC EVALUATION OF THE LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION IN HYPERTENSION (LIFE) STUDY FOR GERMANY
KJ Krobot, GW Carides, A Wagner, TA BurkeVolume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)63668-6
File:
PDF, 67 KB
english, 2006